OT: Nerds chatting [Bioanalytics]

posted by nobody – 2019-03-28 11:14 (748 d 04:29 ago) – Posting: # 20101
Views: 3,881

...and even worse (re Danish footer)

The FDA ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto.

Forty-one out of 194 patients taking AbbVie’s Venclexta (venetoclax) in the company’s trial have died, the FDA found, nearly twice the percent of the patients in the trial’s placebo arm.

Kindest regards, nobody

Complete thread:

Activity
 Admin contact
21,417 posts in 4,475 threads, 1,508 registered users;
online 16 (0 registered, 16 guests [including 1 identified bots]).
Forum time: Wednesday 16:44 CEST (Europe/Vienna)

Old beliefs die hard
even when demonstrably false.    E. O. Wilson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5